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Abstract
Background: Cells expose phosphatidylserine during apoptosis. The voltage across the plasma
membrane also decreases or disappears during apoptosis, but the physiological significance of this
is unknown.
Results:  Here we show that transmembrane potential regulates membrane binding of two
unrelated proteins that recognize exposed phosphatidylserine on apoptotic cells. In Jurkat T
leukemia cells and K562 promyelocytic leukemia cells undergoing apoptosis, extracellular binding
of annexin V was increased by decreasing membrane potential in a dose-dependent manner. Studies
with phospholipid vesicles showed that the effect was mediated via an increase in binding affinity.
The effect was independent of the apoptotic stimulus. The same phenomenon occurred with
lactadherin, a structurally unrelated protein that also binds to apoptotic cells via phosphatidylserine
and is essential for in vivo clearance of dying cells.
Conclusion: Alterations in membrane potential regulate the binding of annexin V and lactadherin
to cell membranes, and may also influence the membrane binding of other classes of
phosphatidylserine-binding proteins.
Background
During apoptosis, many biochemical changes occur to
prepare the cell for death and removal [1]. One well-
known change is the exposure of phosphatidylserine (PS)
early in apoptosis, which is one signal that triggers phago-
cytosis of cells and cell fragments [2]. Exposed PS is recog-
nized both by soluble proteins such as annexins [3,4] and
lactadherin [5], and by membrane receptors on phago-
cytic cells [2,6]. This implies a complex regulatory system
to mark certain cells for phagocytosis while sparing oth-
ers. Annexin V is also widely used as an experimental tool
to detect PS exposure both in vitro and in vivo [7-9]. Thus,
factors regulating the interaction of PS-binding proteins
with cells are likely to be important in both the biological
effector functions of these proteins, and their use as imag-
ing and targeting agents in experimental and diagnostic
studies.
Cells also become depolarized during apoptosis. There is
evidence that plasma membrane potential, in addition to
mitochondrial membrane potential, is decreased early in
apoptosis [10,11]. Although this phenomenon is well
documented, its physiologic significance is unclear [12].
One possible role would be to regulate the binding of
annexins and other PS-binding proteins to apoptotic cells.
In 1997 Hoffmann et al. showed that the binding of
annexin V to artificial phospholipid bilayers could be
modulated by transmembrane potential [13]. However,
Published: 17 February 2009
BMC Biochemistry 2009, 10:5 doi:10.1186/1471-2091-10-5
Received: 13 October 2008
Accepted: 17 February 2009
This article is available from: http://www.biomedcentral.com/1471-2091/10/5
© 2009 Smith et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Biochemistry 2009, 10:5 http://www.biomedcentral.com/1471-2091/10/5
Page 2 of 8
(page number not for citation purposes)
this work involved application of large voltages (up to 200
mV) in an artificial system, so it is unclear whether this
phenomenon would also occur in the much more com-
plex milieu of natural cell membranes with their more
modest transmembrane potentials (typically 70 mV or
less). Our goal was to see if this occurred in more physio-
logic systems. We find that in Jurkat T leukemia and K562
promyelocytic leukemia cells undergoing apoptosis,
extracellular binding of annexin V increases as membrane
potential decreases. Unexpectedly, the same effect was
observed with a structurally unrelated PS-binding protein,
lactadherin. This indicates that membrane potential may
regulate the cellular binding of PS-binding proteins in
general.
Methods
Proteins and cell lines
Cell lines were from the American Type Culture Collec-
tion: Jurkat T leukemia clone E6-1 (ATCC TIB-152) and
chronic myelogenous leukemia line K562 (ATCC TIB-
1520). Recombinant annexin V-117, annexin V-128 and
annexin V-137 [14] were labeled on their single N-termi-
nal cysteine residues with IAF or AlexaFluor680 C2 male-
imide (Invitrogen) [15]. Lactadherin (mouse) from R&D
Systems was labeled with FITC as described [16].
Treatments to induce apoptosis and alter membrane 
potential
Flasks of cells were given fresh media, exposed to 302-nm
UV light for 7.5 min at room temperature, and then put
back in the incubator for 3.5 h. Apoptosis was also
induced with cycloheximide (100 μM), staurosporine
(2.5 μM) or actinomycin D (10 μM) as described for Jur-
kat cells [7]. After treatment, cells were collected by cen-
trifugation and suspended in assay buffer. Most assays
were performed in "A buffer": 10 mM HEPES-Na pH 7.4,
130 mM NaCl, 4 mM KCl, 0.9 mM MgCl2, 0.8 mM
NaH2P04, 5 mM glucose, 1 mg/ml BSA, and unless noted,
1.25 mM CaCl2. Membrane potential was altered with a
high-potassium "B buffer", with the same composition as
A buffer except for 4 mM NaCl and 130 mM KCl. The
potassium ionophore valinomycin and the monovalent
cation ionophore gramicidin were used at 1 μM final con-
centration to alter membrane potential.
Flow cytometric measurements of protein binding and 
membrane potential
Flow cytometry assays were set up with 2.5 to 3.0 × 106
cells/ml in A or B buffer with 30 nM AlexaFluor680-
annexin V-117 and 65 nM of the anionic potentiometric
probe, DiBAC4(3) (Molecular Probes, B438). In some
experiments, DiBAC4(3) was omitted and assays were per-
formed with either 30 nM IAF-annexin V-117 or 20 nM
FITC-lactadherin. After incubation in the dark at 25°C for
6 min, cells were analyzed on a flow cytometer with a 488-
nm laser. The cells were delineated with forward and side-
scatter gating; DiBAC4(3) was read in channel FL1 and
AlexaFluor680-annexin V-117 was read in channel FL3.
FITC and IAF were read in channel FL1. Control experi-
ments showed that the same results were obtained for
cells incubated at 37°C during the annexin V binding
step.
Calcium titrations of phospholipid vesicles to determine 
binding affinity
We used a fluorescence assay to measure the binding of
IAF-annexin V-128 to phospholipid vesicles labeled with
rhodamine; as the fluorescent protein binds, the fluores-
cein fluorescence is progressively quenched by resonance
energy transfer, allowing the fraction of bound protein to
be calculated from the observed quenching divided by the
maximum quenching at saturation [15]. Unilamellar
phospholipid vesicles were prepared [16] with 25% PS (1-
palmitoyl,2-oleoyl), 2% rhodamine-labeled phosphati-
dylethanolamine, 20% 1,2-diheptanoyl-phosphatidyl-
choline and 53% 1-palmitoyl,2-oleoyl phosph atidylcho-
line (all from Avanti Polar Lipids, Alabaster, AL). Vesicles
were prepared in a buffer containing 50 mM HEPES-
sodium, pH 7.4, 3 mM NaN3, and either 1) 100 mM NaCl;
or 2) 99 mM NaCl plus 1 mM KCl; or 3) 100 mM KCl.
Assays were performed with vesicles diluted into one of
these three buffers to give various combinations of potas-
sium gradients between the inside and the outside of the
vesicle. Reactions contained 1 nM IAF-annexin V-128, 10
μM phospholipid vesicles, either 0 or 1 μM valinomycin,
and various concentrations of calcium chloride. After a
10-min incubation at 25°C, fluorescence intensity was
measured and fluorescence quenching calculated relative
to the fluorescence intensity seen in the absence of cal-
cium.
Equilibrium binding affinities are reported as the value of
pKd (the negative logarithm of the dissociation constant),
which was obtained from the following model
[14,15,17,18]:
n Ca + Protein + Membrane ↔ Protein*Can*Membrane
(1)
Kd = [Ca]n [Membrane] [Protein]/[Protein*Can*Mem-
brane] (2)
pKd = -log Kd = -(n log EC50 + log [Membrane])
(3)
The EC50 (midpoint of titration curve) and n (slope of
titration curve) values were determined by non-linear
least-squares fitting of the calcium titration curves to the
following function:BMC Biochemistry 2009, 10:5 http://www.biomedcentral.com/1471-2091/10/5
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Q/Qmax = [Ca]n/([Ca]n + EC50 
n)( 4 )
where Q is the observed fluorescence quenching at a given
calcium concentration, and Qmax  is the maximum
quenching observed when all fluorescent protein is
bound to the vesicles. The apparent dissociation constant
of protein for membrane at a constant calcium concentra-
tion can be estimated from [15]:
Kd, app = Kd/[Ca]n (5)
Under the assay conditions used here, the pKd for binding
to vesicles with 25% PS is about 39 in the absence of a
transmembrane voltage gradient [18]. Due to the negative
cooperativity of binding [17], all these quantitative analy-
ses are only applicable at low membrane occupancy, typ-
ically below 10% of the level obtained when the
membrane is fully saturated with protein. Under the assay
conditions used in this study, the phospholipid vesicles
are only 1% saturated when all the added annexin V is
bound.
Results
Transmembrane voltage regulates annexin V binding 
affinity for phospholipid vesicles
We first sought to confirm the findings of Hofmann et al.
[13] in a phospholipid vesicle system that is closer to
physiological conditions. We used the potassium-selec-
tive ionophore valinomycin to create positive or negative
transmembrane diffusion potentials in the presence of
KCl concentration gradients between the outside and the
inside of vesicles containing 25% PS (Table 1). When vali-
nomycin is added, the binding affinity (pKd) of annexin V
for the external face of the membrane increases when the
inside of the vesicle is made more positive (inward gradi-
ent of K+). Likewise, the binding affinity decreases by
about the same amount when the inside of the vesicle is
made more negative (outward gradient of K+), confirming
the expected symmetry of the effect.
The pKd values determined in Table 1 represent the free
energy change that occurs in going from completely cal-
cium-free protein and phospholipid to the final bound
complex of protein-calcium-phospholipid (Equation 1 in
Methods). Under physiologic conditions, some calcium is
already bound to both protein and phospholipid before
the protein-membrane binding event occurs, and there-
fore the incremental free energy change for the protein-
binding step will be less than for the entire reaction
scheme given in Equation 1. One can estimate an appar-
ent dissociation constant for the protein-binding step at a
constant calcium concentration from Equation 5 [15]. To
estimate how large the effect of transmembrane potential
might be under physiologic conditions, we estimated a Kd,
app  that would pertain to protein-membrane binding
interactions occurring at a constant free calcium concen-
tration of 1.25 mM. The theoretical calculation indicates
that the apparent Kd will increase by about a factor of 10
(ΔpKd of 1.0) (see rightmost column in Table 1). How
much this will alter annexin V binding depends in turn on
the apparent affinity for annexin V, and the concentration
of annexin V used in the assay. The affinity of annexin V
for cells is much less than for the phospholipid vesicles
with 25% PS used in Table 1, with pKd values around 30
[15] and apparent Kd values reported in the range from
about 5 to 30 nM [19-21].
Figure 1 shows a family of theoretical curves for the situa-
tion where the Kd, app becomes tenfold tighter as a result of
changes in the membrane potential. When the concentra-
tion of annexin V is far below the apparent Kd, the effect
of membrane potential can be very large (as much as a
ten-fold increase in binding), but as the concentration of
annexin V increases above the apparent Kd, the relative
Table 1: Transmembrane voltage regulates annexin V binding to phospholipid vesicles.
[K+] outside (mM) [K+] inside (mM) Valino-mycin Number of assays EC50 (mM) Slope pKd (experimental) pKd, app at 1.25 mM 
Ca2+ (theoretical)
100 0 - 10 0.113 ± 0.004 8.7 ± 0.2 41.5 ± 1.0 16.2
100 0 + 11 0.116 ± 0.005 10.1 ± 0.4 46.6 ± 1.5 17.2
Difference: +5.1* +1.0
1 100 - 4 0.135 ± 0.003 9.2 ± 0.2 42.5 ± 0.7 15.8
1 100 + 3 0.132 ± 0.004 8.1± 0.1 38.5 ± 0.3 15.0
Difference: -4.0* -0.8
Binding of fluorescein-annexin V-117 to phospholipid vesicles containing 25% PS was measured by calcium titration at low membrane occupancy 
[15] and binding parameters EC50, slope, and pKd (log of binding affinity) were determined as described under Methods. A positive change in pKd 
indicates higher-affinity binding. Assays were performed with the indicated concentrations of KCl outside and inside the vesicles; a transmembrane 
diffusion potential was created by the addition of 1 μM valinomycin, a potassium-selective ionophore. Uncertainties on experimental parameters 
are given as SEM; asterisks indicate differences that are statistically significant (p < 0.02) by two-tailed t test. The theoretical apparent pKd at 1.25 
mM calcium chloride was calculated from Equation 5.BMC Biochemistry 2009, 10:5 http://www.biomedcentral.com/1471-2091/10/5
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increase in binding becomes smaller and smaller.
Although this theoretical analysis does not take account of
all the complexities of binding to natural cell membranes,
it does provide a general guide to the magnitude of the
effect that might be observed with living cells under phys-
iologic conditions.
Depolarization increases binding of annexin V to cells 
undergoing apoptosis
We next tested whether living cells would show altered
annexin V binding as a function of changes in membrane
potential. Jurkat T leukemia cells provide a good model
system, as they normally have a significant resting mem-
brane potential of about -60 mV (i.e., outside positive and
inside negative) [11] and also expose PS early in apoptosis
[7]. When Jurkat cells are treated with UV light, they start
to undergo apoptosis, as shown by the development of a
population of annexin-positive cells (Figure 2, Panel B
versus Panel A). Depolarization with high-potassium
buffer (Panel B, solid line versus dotted line) increases the
average annexin V binding of the annexin-positive popu-
lation, but does not alter the percentage of annexin-nega-
tive cells in either untreated or UV-treated cells. These
results are as predicted from the vesicle binding studies
above, i.e. making transmembrane potential less negative
would increase the binding of annexin V to the external
face of the plasma membrane. The magnitude of the
change in binding is also reasonably consistent with the
theoretical predictions of Figure 1: at an annexin V con-
centration of 30 nM and a starting Kd, app of 10 nM, Figure
1 predicts an increase in binding of about 1.3-fold, con-
sistent with the observed value of about 1.4.
Cells shrink as they progress through apoptosis, and flow
cytometry can detect this change via a decrease in forward-
scatter light intensity (Figure 2C). The subpopulation of
apoptotic cells with the lowest average size showed the
greatest relative increase in annexin binding with depo-
larization (Figure 2D): the mean fluorescence intensity
increased by 83% for this subpopulation, versus 41% for
the entire annexin-positive population in Panel B.
Figure 1 also predicts that assays performed under condi-
tions that lower the average affinity of binding should
show a relatively larger effect of depolarization on the
binding of annexin V. To test this, we performed assays at
different calcium concentrations, which will vary the Kd,
app  (Equation 5). As shown in Figure 3, the relative
increase in annexin V binding due to depolarization
becomes greater as binding affinity decreases at lower cal-
cium concentrations, consistent with the predictions from
Figure 1.
To further characterize the effect of depolarization, we
tested several different depolarizing treatments (Figure 4).
Treatment of apoptotic Jurkat cells with various combina-
tions of high-potassium buffer, valinomycin (a potas-
sium-selective ionophore) or gramicidin (a non-specific
ionophore for both sodium and potassium) all caused
increased annexin V binding (Figure 4, Panel A). The rela-
tive increase in annexin V binding correlated with the
degree of membrane depolarization as measured by the
membrane-potential-sensitive dye DiBAC4(3) (Panel B).
We also tested a second cell line: the promyelocytic leuke-
mia cell line K562 showed a similar increase in annexin V
binding in response to the same treatments (Panel C). We
also verified that the observed effect was not limited to
UV-treated Jurkat cells. We observed the same pattern of
increased annexin V binding in response to depolariza-
tion with high-potassium buffer for Jurkat cells treated
with cycloheximide (annexin binding ratio of 1.20 ± 0.02,
mean ± SEM, n = 4 experiments), staurosporine (1.17, sin-
gle experiment) and actinomycin D (1.24, single experi-
ment).
Theoretical calculation of how increased binding affinity due  to depolarization could increase annexin V binding under dif- ferent conditions of affinity and ligand concentration Figure 1
Theoretical calculation of how increased binding 
affinity due to depolarization could increase annexin 
V binding under different conditions of affinity and 
ligand concentration. Five theoretical binding isotherms 
were calculated for Kd values of 1, 3, 10, 30, and 100 nM 
from the Langmuir isotherm (bound fraction = [annexin V]/
([annexin V] + Kd)). These curves were then used to calcu-
late the effect of a ten-fold increase in binding affinity (ΔpKd 
of +1) on the relative amount of annexin V bound to a cell 
for three different situations: Kd changes from 10 nM to 1 nM 
(left curve); 30 to 3 nM (middle curve); 100 to 10 nM (right 
curve). The Kd range from 1 to 100 nM was chosen for illus-
tration because experimental apparent Kd values for annexin 
V binding to cells are in this general range [19-21]. The verti-
cal bar indicates the experimentally observed range of depo-
larized/undepolarized binding ratios under the various 
experimental conditions used in this study (see subsequent 
figures).
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Several controls were done to rule out potential alterna-
tive explanations for the observed effect. To verify that
treatment with high-potassium buffer was not by itself
increasing PS exposure, we showed that transient preincu-
bation in high-potassium B buffer did not increase
annexin V binding of cells subsequently assayed in low-
potassium A buffer. Decreased membrane potential
increased the binding of annexin V labeled with different
fluorophores (fluorescein and AlexaFluor680) attached to
either amino groups or the N-terminal cysteine, indicating
that the change in fluorescence signal was not due to
effects on the fluorophore per se. Experiments with a
mutant form of annexin V (annexin V-137 [14]) that lacks
PS binding activity showed no binding to normal or apop-
totic cells in either A or B buffer, ruling out a process of
non-specific uptake in dead or dying cells. The effect was
observed when the assay was performed in the presence of
10% fetal calf serum, indicating that proteins typically
present in the extracellular milieu would not mask PS
binding sites in vivo. The same effect was seen when cells
were labeled with annexin V at either 22° or 37°, and over
a range of annexin V and calcium concentrations.
Depolarization also increases the binding of lactadherin, 
another PS binding protein structurally unrelated to 
annexin V
To evaluate the generality of this phenomenon, we tested
lactadherin, a PS-binding protein that is structurally unre-
lated to annexins and is known to bind to apoptotic cells
[5,22,23] and promote their phagocytic clearance [5,24].
Lactadherin binds to apoptotic cells in the same manner
as annexin V (Figure 5, dashed line). Depolarization of
cells with high-potassium buffer (Figure 5, solid line)
increased binding of lactadherin to PS-positive cells to
about the same degree as for annexin V.
Depolarization increases binding of annexin V to cells with exposed PS Figure 2
Depolarization increases binding of annexin V to cells with exposed PS. Jurkat cells were left untreated (Panel A) or 
were exposed to UV light to induce apoptosis (Panel B). After 3.5 h, cells were assayed by flow cytometry with fluorescein-
annexin V-117. Most of the UV-treated cells have entered the apoptotic pathway and have exposed PS on the extracellular face 
of the plasma membrane, as indicated by the development of a sizable population of annexin-positive cells. Depolarization with 
high-potassium Buffer B (solid lines) increases the mean fluorescence intensity of annexin-positive cells about 41% compared to 
results obtained in low-potassium Buffer A (dashed lines). However, depolarization does not alter the mean fluorescence of 
the annexin-negative population in either untreated or UV-treated cells. The horizontal bars in the lower part of Panel B indi-
cate the gates used to define the annexin-negative and annexin-positive cell populations to allow calculation of mean fluores-
cence intensities for these cell populations. Panel C: Forward-scatter histograms for untreated cells or UV-treated cells. The 
horizontal line indicates the gate used to define the shrunken cells that are observed only in apoptosis. Panel D: Annexin V his-
tograms for the shrunken apoptotic cells assayed in low-potassium A buffer (dashed lines) or high-potassium B buffer (solid 
lines). Depolarization increases annexin V binding to this population by about 83%.
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Discussion
This study shows that transmembrane potential regulates
the binding of PS-binding proteins to apoptotic cells. This
phenomenon appears to be general, since it was observed
with two structurally unrelated PS binding proteins
(annexin V and lactadherin), on two different cell lines, in
response to multiple apoptotic stimuli and multiple
means of depolarizing cells. The effect is seen under phys-
iologic conditions of pH, ionized calcium, and other
extracellular ions. Theoretical analysis (Figure 1 and refer-
ences [14,15,17,18]) predicts that the magnitude of the
effect can vary greatly depending on many factors: the
magnitude and sign of the membrane potential; the con-
centrations of calcium, annexin V, and cells or phosphol-
ipids in the assay; the percentage of PS in the membrane;
and the fractional occupancy of membrane binding sites.
This predicted variability is borne out in practice, as we
have seen relative increases in annexin V binding any-
where from 20% to 400% in this study depending on
assay conditions.
For experimental convenience, most of our experiments
were performed at a relatively high concentration of
annexin V (30 nM), which will tend to decrease the mag-
nitude of the observed effect (cf. Figure 1). In vivo, the
extracellular concentration of annexin V is usually far
lower than this (0 – 10 pM in human plasma samples
[25]), which would tend to magnify the relative effect of
membrane potential on the binding of annexin V. Like-
wise, the doses of annexin V typically given for apoptosis
imaging studies in humans (0.3–0.5 mg) would result in
concentrations in the extracellular fluid of < 1 nM. In
addition, even more factors will come into play in vivo,
such as the concentrations of potential competitor pro-
teins, and it is therefore difficult to make quantitative pre-
dictions about the effect of membrane potential on the
binding of annexin V or lactadherin to cells in vivo. Nev-
ertheless, even relatively modest increases in cell-surface
density of bound annexin V or bound lactadherin on
apoptotic cells could be enough to substantially increase
phagocytosis, particularly if the recognition of these pro-
teins by their cognate receptors on neighboring phago-
cytic cells is nonlinear. The macrophage uptake of
apoptotic Jurkat cells is nonlinear in relation to the
amount of PS exposed [26], and phagocytosis of apop-
totic thymocytes also shows a very steep dependence on
the concentration of lactadherin added to the assay [5].
At this point, the mechanism underlying this effect is
unknown. The fact that it occurs with two structurally
unrelated proteins and with pure phospholipid vesicles
suggests it is likely due to an effect on the phospholipid
component of the cell membrane rather than on the pro-
tein  per se. The binding affinity of annexins for mem-
branes is very strongly influenced by the local density of
PS [15,18], so the effect of membrane potential might be
mediated via its effect on the mobility and/or clustering of
PS. Less is known about the mechanism of lactadherin-
membrane binding, but a similar process could occur as
well. Since lactadherin binding is calcium-independent,
this suggests that the effect of membrane potential on
binding may not be mediated via calcium. It will be inter-
esting to see if this phenomenon occurs with other fami-
lies of proteins that recognize PS or other anionic
phospholipids, such as C2-domain proteins like protein
kinase C isozymes, and coagulation factors V and VIII. It
is also unknown whether this effect will occur with pro-
teins that bind to neutral phospholipids such as phos-
phatidylcholine.
Our results imply that alterations in transmembrane
potential may also regulate the extracellular dynamics of
annexin-membrane binding in other states besides apop-
tosis. Although the effects of hypoxia and ischemia on
neurons are complex, one effect is substantial plasma
membrane depolarization, due in part to the loss of cellu-
lar ATP required to maintain normal potassium gradients
[27]. A similar phenomenon would occur in other tissues
such as the heart. Thus, the observed alterations in
annexin V uptake in vivo in myocardial [28], neuronal
Depolarization causes larger relative increases in annexin V  binding at lower calcium concentrations Figure 3
Depolarization causes larger relative increases in 
annexin V binding at lower calcium concentrations. 
Jurkat cells were treated with UV light, then assayed by flow 
cytometry 3.5 h later. Cells were assayed with Alexa-680-
annexin V-117 in either Buffer A or Buffer B with the indi-
cated concentration of calcium chloride. The subpopulation 
of small apoptotic cells was selected with a forward-scatter 
gate as shown in Figure 2C, and the mean annexin V fluores-
cence of this population was calculated. The graph shows the 
ratio of mean annexin V fluorescence in depolarizing buffer 
to mean annexin V fluorescence in non-depolarizing buffer at 
each calcium concentration.
1
2
3
4
0.5 1 1.5 2 2.5
[CaCl2], mM
B
o
u
n
d
 
A
n
n
e
x
i
n
 
(
d
e
p
o
l
a
r
i
z
e
d
)
/
 
B
o
u
n
d
 
A
n
n
e
x
i
n
(
u
n
d
e
p
o
l
a
r
i
z
e
d
)BMC Biochemistry 2009, 10:5 http://www.biomedcentral.com/1471-2091/10/5
Page 7 of 8
(page number not for citation purposes)
[29,30] and skeletal muscle [31] ischemia may be strongly
influenced by the state of the membrane potential in addi-
tion to the level of exposed PS. This could also help
explain the ready reversibility of annexin V uptake in
some of these conditions [31]: restoration of normal
blood and oxygen supply would allow rapid restoration
of the normal transmembrane ion gradients that are
required to maintain membrane potential. Reduction in
annexin V binding would thus not necessarily require
transmembrane transport of PS to remove exposed PS
from the extracellular face of the plasma membrane.
Another intriguing possibility raised by our results is that
changes in membrane potential could also regulate the
intracellular  binding of annexins. The situation at the
intracellular face of the plasma membrane would be the
mirror image of what is observed at the extracellular face,
i.e. as a cell depolarizes and transmembrane potential
becomes less negative, this would decrease binding of
intracellular annexins to the intracellular face of the
plasma membrane. Annexins are primarily intracellular,
cytoplasmic proteins, but their attachment to subcellular
membranes can vary in response to multiple stimuli
[32,33]. Perhaps at least some of these effects are medi-
ated via alterations in membrane potential.
Conclusion
Transmembrane potential may be a regulator of mem-
brane binding of annexins and lactadherin in both nor-
mal physiology and disease states.
Abbreviations
Buffer A: 10 mM HEPES-Na pH 7.4, 130 mM NaCl, 4 mM
KCl, 0.9 mM MgCl2, 0.8 mM NaH2P04, 5 mM glucose, 1
mg/ml BSA, and 1.25 mM CaCl2; Buffer B: same as Buffer
A except for 4 mM NaCl and 130 mM KCl; DiBAC4(3):
Effect of depolarizing agents on annexin V binding to apoptotic Jurkat and K562 cells Figure 4
Effect of depolarizing agents on annexin V binding to apoptotic Jurkat and K562 cells. Panel A: Jurkat cells were 
treated with UV light; 3.5 h later, cells were assayed in one of the following buffers: buffer A; buffer B; buffer A + 1 μM grami-
cidin; buffer B + 1 μM gramicidin; buffer B + 1 μM valinomycin. Results are expressed as the mean fluorescence of the annexin-
positive cells for each treatment relative to the mean fluorescence of cells assayed in non-depolarizing A buffer. Results are 
mean ± SEM for two to nine independent experiments for each treatment; all treatment/control ratios are significantly differ-
ent from 1.0 by two-tailed t test (p < 0.02). Panel B: Correlation between increased annexin V binding and degree of depolari-
zation as measured with the membrane-potential-sensitive dye DiBAC4(3). Jurkat cells treated as described in Panel A were 
assayed by two-color flow cytometry with DiBAC4(3) and AlexaFluor680-annexin V-117. DiBAC4(3) uptake increases as mem-
brane potential becomes less negative. Panel C: K562 cells were treated with UV light and then assayed as described in Panel 
A. Results are mean ± SEM of two to four independent experiments; all treatment/control ratios are significantly different from 
1.0 by two-tailed t test (p < 0.02).
Depolarization increases the binding of lactadherin to apop- totic cells Figure 5
Depolarization increases the binding of lactadherin 
to apoptotic cells. Jurkat cells were prepared as described 
in the legend to Figure 2, and were then assayed with fluores-
cein-lactadherin in low-potassium A buffer (dashed lines) or 
depolarizing high-potassium B buffer (solid line). Assay in B 
buffer increased the mean fluorescence of the lactadherin-
positive cell population by an average of 33 ± 2% compared 
to cells assayed in A buffer (mean ± SEM of three separate 
experiments). Horizontal lines indicate the gates used to 
define lactadherin-negative and lactadherin-positive cells.
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bis-(1,3-dibutylbarbituric acid)trimethine oxonol; EC50:
calcium concentration causing 50% of maximum protein-
membrane binding; FITC: fluorescein 5-isothiocyanate;
IAF: 5-iodoacetamidofluorescein; pKd: negative logarithm
of equilibrium dissociation constant; PS: phosphatidyl-
serine; SEM: standard error of the mean; UV: ultraviolet.
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